Lesions in the Fundus of the Eye in Patients with Acute Leukemia. Who Has, When and Why?

Acute leukemia is a formidable disease that often leads to the death of the patient from the underlying disease or the consequences of severe chemotherapy treatment. Many prognostically unfavorable factors are known, including genetic and epigenetic ones. The review is devoted to the prognostic significance of changes in the fundus in patients with acute leukemia. According to various literature sources, ophthalmic manifestations of leukemia can be observed in 9-90% of cases. The data is obtained from the sources: eLibrary.RU, in the international PubMed database, as well as on the electronic websites of specialized scientific journals. Retinal hemorrhages, according to various authors, are associated with changes in peripheral blood. At the moment, there is no consensus on whether eye damage in acute leukemia is a bad prognostic sign. Are changes in peripheral blood related to pathologies on the fundus? It is not clear in which case, and in which patients, they may indicate an unfavorable prognosis. Is there a relationship between fundus lesions in acute leukemia and already known genetic and epigenetic adverse prognostic factors? All these unresolved issues require further detailed research of patients with acute leukemia and changes in the fundus.

1. Clinical oncohematology. A manual for the physician. Ed. By M.A. Volkova. 2nd edition, updated. Moscow: Meditsina Publ., 2007. 1120 p. (In Russ.)

2. De Kouchkovsky I, AbdulHay M. Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J. 2016 Jul 1;6(7):e441. doi: 10.1038/bcj.2016.50.

3. Yang X, Chen H, Man J, Zhang T, Yin X, He Q, Lu M. Seculartrends in the incidence and survival of all leukemia types in the United States from 1975 to 2017. J Cancer. 2021 Feb 22;12(8):2326–2335. doi: 10.7150/jca.52186.

4. Bispo JAB, Pinheiro PS, Kobetz EK. Epidemiology and Etiology of Leukemia and Lymphoma. Cold Spring Harb Perspect Med. 2020 Jun 1;10(6):a034819. doi: 10.1101/cshperspect.a034819.

5. Ilhan G, Karakus S, Andic N. Risk factors and primary prevention of acute leukemia. Asian Pac J Cancer Prev. 2006 OctDec;7(4):515–517.

6. Radzhabova AM, Voloshin SV, Martynkevich IS, Kuzyaeva AA, Shuvaev V, Motyko EV, Kuvshinov AYu, Fominykh MS, Schmidt AV, Polushkina LB, Bakay MP, Tiranova SA, Zenina MN, Potihonova NA, Kudryashova S, Balashova VA, Chubukina ZhV, Uspenskaya OS, Karyagina EV, Bogdanov AN, Chechetkin AV. Role of FLT3 gene mutations in acute myeloid leukemia: effect on course of disease and results of therapy. Genes & Cells. 2019;14(1):55–61 (In Russ.). doi: 10.23868/201903007.

7. Zhao JC, Agarwal S, Ahmad H, Amin K, Bewersdorf JP, Zeidan AM. A review of FLT3 inhibitors in acute myeloid leukemia. Blood Rev. 2022 Mar;52:100905. doi: 10.1016/j.blre.2021.100905.

8. Petrova EV, Martynkevich IS, Polushkina LB, Martynenko LS, Ivanova MP, Cybakova NYu, Kleina EV, Shabanova ES, Chechetkin AV, Abdulkadyrov KM. Clinical, hematological and moleculargenetic features of acute myeloid leukemia with mutations in FLT3, CKIT, NRAS and NPM1. Hematology and transfusiology. Russian journal (Gematologiya i Transfusiologiya). 2016;61(2):72–80 (In Russ.). doi: 10.18821/0234-5730-2016-61-2-72-80.

9. RauseiMills V, Chang KL, Gaal KK, Weiss LM, Huang Q. Aberrant expression of CD7 in myelablasts is highly associated with de novo acute myeloid leukemias with FLT31TD mutation. Am. J. Cin. Pathol. 2009;129(4):624–629.

10. Gritsayev SV, Chubukina ZhV, Martynkevich IS, Kostroma II, Glazanova TV, Petrova EV, Martynenko LS, Tiranova SA, Potikhonova NA, Zyuzgin IS, Bubnova LN, Abdulkadyrov KM. Clinicohematological and molecular genetic variability of acute myeloid leukemia with CD7 expression on blasts cells. Clinical oncohematology. 2013;4(6):427–433 (In Russ.).

11. Hallek M, Cheson BD, Catovsky D, CaligarisCappio F, Dighiero G, Döhner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ; Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) updating the National Cancer InstituteWorking Group (NCIWG) 1996 guidelines. Blood. 2008;111(12):5446–5456.

12. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999 Sep 15;94(6):1840–1847.

13. StetlerStevenson M, Arthur DC, Jabbour N, Xie XY, Molldrem J, Barrett AJ, Venzon D, Rick ME. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood. 2001 Aug 15;98(4):979–987. doi: 10.1182/blood.v98.4.979.

14. Del Poeta G, Stasi R, Venditti A, Cox C, Aronica G, Masi M, Bruno A, Simone MD, Buccisano F, Papa G. CD7 expression in acute myeloid leukemia. Leuk Lymphoma. 1995 Mar;17(1–2):111–119. doi: 10.3109/10428199509051710.

15. Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G, Bruno A, Masi M, Tabilio A, Papa G. Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Leukemia. 1994 Mar;8(3):388–394.

16. Tiftik N, Bolaman Z, Batun S, Ayyildiz O, Isikdogan A, Kadikoylu G, Muftuoglu E. The importance of CD7 and CD56 antigens in acute leukaemias. Int J Clin Pract. 2004 Feb;58(2):149–152. doi: 10.1111/j.1368-5031.2004.0018.x.

17. Pinheiro LHS, Trindade LD, Costa FO, Silva NL, Sandes AF, Nunes MAP, Correa CB, Almeida CAC, da Cruz GS, de Lyra Junior DP, Schimieguel DM. Aberrant Phenotypes in Acute Myeloid Leukemia and Its Relationship with Prognosis and Survival: A Systematic Review and MetaAnalysis. Int J Hematol Oncol Stem Cell Res. 2020 Oct 1;14(4):274–288. doi: 10.18502/ijhoscr.v14i4.4484.

18. Peters JM, Ansari MQ. Multiparameter Flow Cytometry in the Diagnosis and Management of Acute Leukemia. Arch Pathol Lab Med. 2011;135:44–54. doi: 10.5858/2010-0387-RAR.1.

19. Liang T, Peng Z, Li C, Huang J, Wang H, Bu C, Li J, Zheng Y, Feng X, Li H, Chen C. Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia. BMC Cancer. 2022 Dec 21;22(1):1339. doi: 10.1186/s12885-022-10460-3.

20. Aref S, Azmy E, ELBakry K, Ibrahim L, Mabed M. Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patients. Hematology, 2018;23(5):263–270. doi: 10.1080/10245332.2017.1404276.

21. Ali Shah M, Ahmad U, Tariq Mahmood M, Ahmad AH, Abu Bakar M. Frequency of CD34 and CD10 Expression in Adolescent and Young Adult Patients Having Precursor Bcell Acute Lymphoblastic Leukemia and Its Correlation With Clinical Outcomes: A SingleCenter Study. Cureus. 2022 Jan 15;14(1):e21261. doi: 10.7759/cureus.21261.

22. Cascavilla N, Musto P, D’Arena G, Ladogana S, Matera R, Carotenuto M. Adult and childhood acute lymphoblastic leukemia: clinicobiological differences based on CD34 antigen expression. Haematologica. 1997 JanFeb;82(1):31–37.

23. Dakka N, Bellaoui H, Bouzid N, Khattab M, Bakri Y, Benjouad A. CD10 AND CD34 expression in childhood acute lymphoblastic leukemia in Morocco: clinical relevance and outcome. Pediatr Hematol Oncol. 2009 Jun;26(4):216–231. doi: 10.1080/07357900902897557.

24. Myint H, Lucie NP. The Prognostic Significance of the CD34 Antigen in Acute Myeloid Leukaemia. Leukemia & Lymphoma. 1992;7(5–6):425–429. doi: 10.3109/10428199209049798.

25. Guo RJ, Atenafu EG, Schimmer AD, Minden MD, Chang H. Expression of CD4 is correlated with an unfavorable prognosis in wildtype NPM1, FLT3ITDnegative cytogenetically normal adult acute myeloid leukemia. Int J Lab Hematol. 2017 Aug;39(4):429–437. doi: 10.1111/ijlh.12649.

26. Paydas S, Zorludemir S, Ergin M. Granulocytic sarcoma: 32 cases and review of the literature. Leuk Lymphoma. 2006;47(12):2527–2541.

27. Guyer DR, Schachat AP, Vitale S, Markowitz JA, Braine H, Burke PJ, Karp JE, Graham M. Leukemic retinopathy. Relationship between fundus lesions and hematologic parameters at diagnosis. Ophthalmology. 1989 Jun;96(6):860–864. doi: 10.1016/s016164-20(89)32809-0.

28. Orhan B, Malbora B, Akça Bayar S, Avcı Z, Alioğlu B, Özbek N. Ophthalmologic Findings in Children with Leukemia: A SingleCenter Study. Turk J Ophthalmol. 2016 Apr;46(2):62–67. doi: 10.4274/tjo.03880.

29. Koshy J, John MJ, Thomas S, Kaur G, Batra N, Xavier WJ. Ophthalmic manifestations of acute and chronic leukemias presenting to a tertiary care center in India. Indian J Ophthalmol. 2015 Aug;63(8):659–664. doi: 10.4103/0301-4738.169789.

30. Skarsgård LS, Andersson MK, Persson M, Larsen AC, Coupland SE, Stenman G, Heegaard S. Clinical and genomic features of adult and paediatric acute leukaemias with ophthalmic manifestations. BMJ Open Ophthalmol. 2019 Oct 3;4(1):e000362. doi: 10.1136/bmjophth-2019-000362.

31. Ghanbarnia M, Sedaghat S, Rasoulinejad SA. Leukemic retinopathy presenting as concurrent bilateral subhyaloid hemorrhage and subarachnoid hemorrhage in a patient with acute monocytic leukemia: a case report. J Med Case Rep. 2022 Dec 17;16(1):466. doi: 10.1186/s13256-022-03700-4.

32. Lang GE, Lang SJ. Augenveränderungen bei hämatologischen Erkrankungen [Ocular findings in hematological diseases]. Ophthalmologe. 2011 Oct;108(10):981–993; quiz 994. German. doi: 10.1007/s00347-011-2430-x.

33. Hafeez MU, Ali MH, Najib N, Ayub MH, Shafi K, Munir M, Butt NH. Ophthalmic Manifestations of Acute Leukemia. Cureus. 2019 Jan 7;11(1):e3837. doi: 10.7759/cureus.3837.

34. Bukhari ZM, Alzahrani A, Alqarni MS, Alajmi RS, Alzahrani A, Almarzouki H, Alqahtani AS. Ophthalmic Manifestations in Acute Leukemia Patients and Their Relation With Hematological Parameters in a Tertiary Care Center. Cureus. 2021 Nov 8;13(11):e19384. doi: 10.7759/cureus.19384.

35. Bouazza M, Youssefi H, Bouanani N. Ocular Manifestations in Hematological Disorders. Cureus. 2022 Aug 12;14(8):e27941. doi: 10.7759/cureus.27941.

36. Silva D, Mota M, Bilé A, Ramalho M, Pinto S, Pires G, Teixeira S, Prieto I. Unilateral leukemic infiltration and acute angle closure as the first sign of Bcell acute lymphoblastic leukemia relapse. GMS Ophthalmol Cases. 2019 Apr 26;9:Doc16. doi: 10.3205/oc000105.

37. Talcott KE, Garg RJ, Garg SJ. Ophthalmic manifestations of leukemia. Curr Opin Ophthalmol. 2016 Nov;27(6):545–551. doi: 10.1097/ICU.0000000000000309.

38. Bitirgen G, Belviranli S, Caliskan U, Tokgoz H, Ozkagnici A, Zengin N. Ophthalmic manifestations in recently diagnosed childhood leukemia. Eur J Ophthalmol. 2016 JanFeb;26(1):88–91. doi: 10.5301/ejo.5000647.

39. Dhasmana R, Prakash A, Gupta N, Verma SK. Ocular manifestations in leukemia and myeloproliferative disorders and their association with hematological parameters. Ann Afr Med. 2016 JulSep;15(3):97–103. doi: 10.4103/1596-3519.188887.

40. Reddy SC, Jackson N. Retinopathy in acute leukaemia at initial diagnosis: correlation of fundus lesions and haematological parameters. Acta Ophthalmol Scand. 2004 Feb;82(1):81–85. doi: 10.1046/j.1600-0420.2003.00197.x.

41. Ghanbarnia M, Sedaghat S, Rasoulinejad SA. Leukemic retinopathy presenting as concurrent bilateral subhyaloid hemorrhage and subarachnoid hemorrhage in a patient with acute monocytic leukemia: a case report. J Med Case Rep. 2022 Dec 17;16(1):466. doi: 10.1186/s13256-022-03700-4.

42. Lyu S, Zhang M, Gao Y. Acute bilateral retina hemorrhages beneath internal limiting membrane: An unusual ophthalmological case report of acute leukemia during complete clinical remission. Medicine (Baltimore). 2018 Feb;97(7):e0000. doi: 10.1097/MD.0000000000010000.

43. Berradi S, Daoudi R. Whitecentered retinal hemorrhage. Pan Afr Med J. 2014 Mar 27;17:233. doi: 10.11604/pamj.2014.17.233.4038.

44. Ben Abdesslem N, Zaafrane N, Ben Abderazek A, Jabri A, Mahjoub A, Ben Youssef C, Mahjoub H, Krifa F, Mahjoub A. Whitecentered retinal hemorrhage revealing acute leukemia: A case report. Ann Med Surg (Lond). 2022 Apr 15;77:103632. doi: 10.1016/j.amsu.2022.103632.

45. Chaabani L, Doulami K. Whitecentred retinal hemorrhage revealing acute leukemia. Tunis Med. 2019 Jun;97(6):822–825.

46. abu elAsrar AM, alMomen AK, Kangave D, Harakati MS, Ajarim DS. Correlation of fundus lesions and hematologic findings in leukemic retinopathy. Eur J Ophthalmol. 1996 AprJun;6(2):167–172. doi: 10.1177/112067219600600213.

47. Chandra A, Chakraborty U, Ganai S, Ray AK. Roth spots in acute myeloid leukaemia. BMJ Case Rep. 2020 Sep 2;13(9):e238133. doi: 10.1136/bcr-2020-238133.

48. Zyrina GV. Neuroleukemia in patients with acute leukemia as a neurological problem. Neurological journal. 2012;17(5):6–19 (In Russ.).

49. Esteller D, DoncelMoriano A, Claro M, Tardón L, NavarroOtano J, Martínez Hernández E, SuárezLledó M, Alejaldre A. Isolated multiple neuropathy as clinical manifestation of leukemia relapse. Rev Neurol. 2022 Aug 16;75(4):93–95. doi: 10.33588/rn.7504.2021367.

50. Yoshida K, Hasegawa D, Takusagawa A, Kato I, Ogawa C, Echizen N, Ohkoshi K, Yamaguchi T, Hosoya R, Manabe A. Bullous exudative retinal detachment due to infiltration of leukemic cells in a child with acute lymphoblastic leukemia. Int J Hematol. 2010 Oct;92(3):535–537. doi: 10.1007/s12185-010-0683-9.

51. Johnson JS, Lopez JS, Kavanaugh AS, Liang C, Mata DA. A 25YearOld Man with Exudative Retinal Detachments and Infiltrates without Hematological or Neurological Findings Found to Have Relapsed Precursor TCell Acute Lymphoblastic Leukemia. Case Rep Ophthalmol. 2015 Sep 15;6(3):321–327. doi: 10.1159/000439375.

52. Patel AV, Miller JB, Nath R, Shih HA, Yoon MK, Freitag SK, Papaliodis G, Chen TC, Eliott D, Kim IK. Unilateral Eye Findings: A Rare Herald of Acute Leukemia. Ocul Oncol Pathol 1 April 2016;2(3):166–170. https://doi.org/10.1159/000442951.

53. Gustov AV, Sigriansky KI, Stolyarova ZhP. Practical neuroophthalmology. 2nd ed. N. Novgorod: Publishing House of the Nizhny Novgorod State Medical Academy, 2003;1:57, 86–87 (In Russ.).

54. Grishina EE, Ryabtseva AA, Andryuhina OM, Kovrizhkina AA. The role of optical coherence tomography in the diagnosis of the leukemic infiltration of the optic nerve and retina. Russian Ophthalmological Journal. 2021;14(4):46–51 (In Russ.). doi: 10.21516/2072-0076-2021-14-4-46-51.

55. Primack JD, Smith ME, Tychsen L. Retinal detachment in a child as the first sign of leukemic relapse: histopathology, MRI findings, treatment, and tumorfree follow up. J Pediatr Ophthalmol Strabismus. 1995 JulAug;32(4):253–256. doi: 10.3928/0191-3913-19950701-13.

56. Azık FM, Akıncı A, Saylı TR, Culha VK, Teberik K, Teke MY, Gürbüz F. Unilateral exudative retinal detachment as the sole presentation of relapsing acute lymphoblastic leukemia. Turk J Haematol. 2012 Jun;29(2):181–184. doi: 10.5505/tjh.2012.72623.

57. Grishina EE, Ryabtseva AA, Andryukhina OM, Mamontov AO. Leukemic optic nerve infiltration as the first symptom of neuroleukemia. Russian Ophthalmological Journal. 2016;9(4):64–68 (In Russ.). doi: 10.21516/2072-0076-2016-9-4-64-68.

58. Hematology. National Guidelines for Hematology. Ed. by O.A. Rumyantsev. Moscow: GEOTARMedia, 2019;358–359 (In Russ.).

59. Grishina EE, Ryabtseva AA, Andryukhina OM, Kovrizhkina AA. Various Types of Neuroleukemia with Optic Nerve Involvement. Ophthalmology in Russia. 2020;17(3):375–381 (In Russ.). doi: 10.18008/1816-5095-2020-3-375-381.

60. El Salloukh NA, Hage DG, Bashshur AZ, Kheir WJ. Early Ophthalmological Manifestations of Acute Myeloid Leukemia: Current Perspectives. Clin Ophthalmol. 2022 Jul 1;16:2119–2127. doi: 10.2147/OPTH.S342720.

61. Wang WY, Lin CW. Vitreous cytology as the only diagnostic evidence of central nervous system involvement in a patient with isolated leukemic infiltrative optic neuropathy. Taiwan J Ophthalmol. 2021 Mar 9;12(3):339–342. doi: 10.4103/tjo.tjo_89_20.

62. Uhr JH, Thau A, Chung C, Zhang XC. Rare presentation of bilateral central retinal vein occlusion and leukemic retinopathy in a young adult diagnosed with Tcell acute lymphoblastic leukemia. Cureus. 2020;12(1):e6666. doi: 10.7759/cureus.6666.

63. Ohkoshi K, Tsiaras WG. Prognostic importance of ophthalmic manifestations in childhood leukaemia. Br J Ophthalmol. 1992 Nov;76(11):651–655. doi: 10.1136/bjo.76.11.651.